Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

24 Jul 2014 15:28

RNS Number : 2704N
Biome Technologies PLC
24 July 2014
 



 

24 July 2014

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes a trading update, ahead of its interim results for the six-month period ended 30 June 2014, which are expected to be announced on 3 September 2014.

 

Trading Update

 

Total Group revenues achieved for the second quarter of 2014 were £1.2m (Q1 2014: £1.1m; Q2 2013: £0.5m). The turnover for the second quarter maintains the significant progress made in the first quarter of 2014 compared to the same period in the prior year and means that revenues generated by the Group in the first half of 2014 at £2.3m are now in excess of those for the full year of 2013.

 

The Group's cash position at 30 June 2014 was £3.1m (31 March 2014: £3.2m).

 

The business continues to make good progress with the strategy to commercialise and develop wholly owned intellectual property. Performance in the first half was ahead of the Board's expectations for both divisions.

 

Bioplastics Division

 

Q2 2014 revenues for the Bioplastics Division were £0.6m (Q1 2014: £0.5m; Q2 2013: £0.1m) 21% ahead of Q1 2014 performance. Revenues generated by the Bioplastics Division in the first half of 2014 were therefore £1.1m, already in excess of the £1.0m full year 2013 revenue.

 

The focus of the division on developing high margin, application led bioplastic polymers with enhanced level of functionality is starting to take hold. Increasing volumes of Biome's materials were procured in the period for use in the US single-serve coffee market amongst other applications. Further progress was made in the development of the pipeline of new products with technical and customer trials continuing in both the food service and paper-board coating sectors.

 

The division announced the successful completion of a feasibility study undertaken in conjunction with the University of Warwick's Centre for Biotechnology and Biorefining and supported by the Government-backed Technology Strategy Board (TSB).

 

Stanelco RF Technologies Division

 

Q2 2014 revenues for the RF Division were £0.6m (Q1 2014: £0.6m; Q2 2013: £0.4m) maintaining the promising start that the division made in the first quarter of the year. Revenues for the first half of 2014 were £1.2m and are now in excess of the revenues achieved by this division for the full year 2013.

 

Activity and ordering levels in the first half have been encouraging with some evidence that the market for fibre optic furnaces, one of the main repeating products for the division, is experiencing some recovery in Asia. The contract with a customer from a regulated industry has commenced and receipts of approximately one quarter of contract value were received during the first half of 2014. Enquiry and order levels for the business are robust.

 

Group Outlook

 

The Group's revenues and cash are slightly ahead of the Board's expectations at the mid-year point with the reporting of the interim results scheduled for 3 September 2014.

 

This has been a positive first half for the Group and the Board is confident that this progress can be maintained for the full year.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Daniel Stewart & Company plc

David Hart (Nominated Adviser)

Mark Treharne (Broker)

www.danielstewart.co.uk

Tel: +44 (0) 20 7776 6550

Allenby Capital

Chris Crawford/Kelly Gardiner

www.allenbycapital.com

Tel: +44 (0) 20 3002 2070

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQKQDBQBKDOOB
Date   Source Headline
18th Apr 202310:49 amRNSCompletion of CLN Fundraising
17th Apr 202311:30 amRNSResult of General Meeting
31st Mar 202311:14 amRNSProposed issue of Convertible Loan Notes
25th Jan 20237:00 amRNSTrading Update
16th Nov 20227:00 amRNSBiome receives £282k grant
10th Nov 202211:05 amRNSSecond Price Monitoring Extn
10th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTrading Update
18th Oct 20229:28 amRNSHolding(s) in Company
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
5th Sep 20227:00 amRNSGrant funding from Innovate UK
2nd Aug 20228:59 amRNSTrading Update - Replacement
2nd Aug 20227:00 amRNSTrading Update
20th Apr 202212:01 pmRNSResult of Annual General Meeting
20th Apr 20227:00 amRNSTrading Update
30th Mar 20222:48 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSNotice of AGM and 2021 Annual Report
24th Mar 20227:00 amRNSFinal Results 2021
27th Jan 20227:00 amRNSTrading Update
4th Jan 202210:33 amRNSFurther substantial contract win for RF Division
16th Dec 20218:41 amRNSContract
17th Nov 20217:00 amRNSTrading Update
9th Nov 202111:12 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSUpdate re biodegradable tree shelters
15th Sep 20217:00 amRNSInterim Results
30th Jul 20219:47 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSTrading Update
1st Jul 20219:05 amRNSSecond Price Monitoring Extn
1st Jul 20219:00 amRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSTrading Update
30th Jun 20215:00 pmRNSTotal Voting Rights
7th Jun 202110:50 amRNSHolding(s) in Company
2nd Jun 20217:00 amRNSIssue of Equity and TVR
28th May 20217:00 amRNSAward under 2017 Long Term Incentive Plan
30th Apr 20215:00 pmRNSTotal Voting Rights
27th Apr 20214:25 pmRNSHolding(s) in Company
21st Apr 202110:51 amRNSHolding(s) in Company
21st Apr 202110:19 amRNSResult of Annual General Meeting
21st Apr 20217:00 amRNSTrading Update
9th Apr 20211:40 pmRNSPDMR Shareholding and transaction in own shares
1st Apr 202110:04 amRNSIssue of equity and Transaction in own shares
29th Mar 20217:00 amRNSNotice of AGM and Annual Report
25th Mar 20217:01 amRNSFinal Results 2020
25th Mar 20217:00 amRNSAppointment of New Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.